Postoperative sorafenib prolongs survival of hepatocellular carcinoma patients with Portal vein tumor thrombus following hepatic resection Article

Guo, Wei-Xing, Guo, Lei, Wang, Kang et al. (2017). Postoperative sorafenib prolongs survival of hepatocellular carcinoma patients with Portal vein tumor thrombus following hepatic resection . International Journal of Clinical and Experimental Medicine, 10(1), 1615-+.

cited authors

  • Guo, Wei-Xing; Guo, Lei; Wang, Kang; Huang, Bin; Shi, Jie; Li, Nan; Zhou, Fei-Guo; Wu, Meng-Chao; Cheng, Shu-Qun

sustainable development goals

authors

publication date

  • January 1, 2017

published in

keywords

  • EFFICACY
  • Hepatocellular carcinoma
  • INVASION
  • Life Sciences & Biomedicine
  • MULTICENTER
  • Medicine, Research & Experimental
  • PROPENSITY SCORE ANALYSIS
  • RECURRENCE
  • Research & Experimental Medicine
  • Science & Technology
  • THERAPY
  • TRANSARTERIAL CHEMOEMBOLIZATION
  • portal vein thrombosis
  • prognosis
  • resection
  • sorafenib

start page

  • 1615

end page

  • +

volume

  • 10

issue

  • 1